Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Edwards

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|February 17, 2026
Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancerLiqun Yu, Charlotte Rivas, Fengshuo Liu, et al.
British Journal of Cancer|December 1, 2020
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancerDerek Dustin, Guowei Gu, Amanda R Beyer, et al.
Cancer Research|January 7, 2026
Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast CancerSarah K Herzog, Jessica H Stevens, Guowei Gu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Discovery|October 26, 2022
Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ CellsWeijie Zhang, Zhan Xu, Xiaoxin Hao, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonizationZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Cancer Discovery|January 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast CancerRahat Alam, Anna Reva, David G Edwards, et al.
Oncogene|May 12, 2018
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targetsLeah A Gates, Guowei Gu, Yue Chen, et al.
Cell Genomics|May 24, 2025
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonizationFengshuo Liu, Yunfeng Ding, Zhan Xu, et al.
Cell|April 29, 2026
Unbiased niche labeling maps immune-excluded niche in bone metastasisZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|February 17, 2026
Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancerLiqun Yu, Charlotte Rivas, Fengshuo Liu, et al.
British Journal of Cancer|December 1, 2020
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancerDerek Dustin, Guowei Gu, Amanda R Beyer, et al.
Cancer Research|January 7, 2026
Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast CancerSarah K Herzog, Jessica H Stevens, Guowei Gu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Discovery|October 26, 2022
Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ CellsWeijie Zhang, Zhan Xu, Xiaoxin Hao, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonizationZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Cancer Discovery|January 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast CancerRahat Alam, Anna Reva, David G Edwards, et al.
Oncogene|May 12, 2018
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targetsLeah A Gates, Guowei Gu, Yue Chen, et al.
Cell Genomics|May 24, 2025
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonizationFengshuo Liu, Yunfeng Ding, Zhan Xu, et al.
Cell|April 29, 2026
Unbiased niche labeling maps immune-excluded niche in bone metastasisZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Pageof 12